Qiqin Wang
ORCID: 0000-0002-9169-5500
· 2 papers in corpus
preprint
2023
Abstract Objective To investigate the efficacy and safety of dienogest((DNG) monotherapy and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment for adenomyosis. Methods This is a retrospective study.15…
article
2022